Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by Rm90090on May 13, 2020 3:46pm
280 Views
Post# 31024102

RE:RE:RE:RE:Look at the TWEETS about LABS

RE:RE:RE:RE:Look at the TWEETS about LABS

There are three RUMOURS that I saw. One is that they recently fired a number of staff including their CFO. The second is that there is a class action lawsuit against them (don't know why). The third is that they took part in 'double booking revenue'. To be honest I'm Not sure what that third one entails.

Keep in mind these are complete rumours, and probably a lot of BS. I am invested in another extraction company, but if LABS has problems it affects all of the extraction companies at this point in the cannabis industry lifecycle.

If they had to let staff go - I think that would be forgivable during COVID. I do hope Labs addresses things in one way or another.

glta.

Bullboard Posts